MarketLens
Sign Up

What Triggered uniQure's Sudden Stock Plunge

7 months ago
SHARE THIS ON:

What Triggered uniQure's Sudden Stock Plunge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•5 days ago

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law

uniQure N.V. faces a fraud investigation announced by SBS Law, inviting QURE investors to join. No financial terms or timeline were disclosed.
Stock News•5 days ago

Uniqure Plummets 40% On Another Shocking Twist For Its Huntington's Drug

Uniqure shares fell 40% Tuesday after a four-year update on its experimental Huntington's disease gene therapy disappointed investors. The decline reflects renewed uncertainty over the program's durab...
Stock News•1 months ago

RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy

REGENXBIO (RGNX) fell 25% after the FDA placed a clinical hold on RGX-121 for MPS II, following asymptomatic spine MRI findings in five participants.

Breaking News

View All →

Top Headlines

View More →
Stock News•2 hours ago

Forget the S&P 500: SCHD Is Beating It by Nearly 10 Points in 2026 and Its Dividend Just Grew

Stock News•4 hours ago

NVDY: NVIDIA Shares Break To Record Highs, Don't Cede The Upside Now

Stock News•6 hours ago

Is Copilot Microsoft's Secret Weapon in the AI Arms Race?

Stock News•7 hours ago

2 Millionaire-Maker Quantum Computing Stocks to Buy Hand Over Fist

Stock News•7 hours ago

The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It